{"Clinical Trial ID": "NCT00356148", "Intervention": ["INTERVENTION 1:", "Prophylaxis group", "Patients with BMI over 25 years of age receiving ampicillin/sulbactam prophylaxis", "INTERVENTION 2:", "No prophylaxis group", "Patients with BMI over 25 years of age who do not receive a prophylaxis antibiotic"], "Eligibility": ["Incorporation criteria:", "Women at all ages with early breast cancer (stage I-II) and American Society of Anesthesiologists (ASA) I-II score.", "- Exclusion criteria:", "- Ductal cancer in situ (CDIS; stage 0 cancer),", "Advanced or distant metastatic stage,", "receive any neoadjuvant therapy,", "\u2022 History of receipt of antibiotics in the previous 3 months,", "Immunodeficiency history,", "Having a remote infection,", "\u2022 History of reaction to the study of antibiotics,", "\u2022 Refusal to sign the consent form."], "Results": ["Performance measures:", "Number of patients with body mass index (BMI) of more than 25 who developed surgical site infection (SSI) in groups that received antibiotic prophylaxis (prophylaxis group) and not prophylaxis (non-prophylaxis group).", "[Unspecified]", "Time limit: 1 month", "Results 1:", "Title of the arm/group: Prophylaxis Group", "Description of the arm/group: patients with BMI over 25 years of age receiving ampicillin/sulbactam prophylaxis", "Total number of participants analysed: 187", "Type of measurement: Number", "Unit of measurement: participants 9", "Results 2:", "Title of arm/group: No prophylaxis group", "Description of the arm/group: Patients with BMI over 25 years of age who do not receive antibiotic prophylaxis", "Total number of participants analysed: 182", "Type of measurement: Number", "Unit of measurement: participants 25"], "Adverse Events": ["Undesirable Events 1:", "Total: 0/189 (0.00 per cent)", "Adverse Events 2:", "Total: 0/183 (0.00 per cent)"]}